Service Line:+1-315-239-3085
Address:FL-4, Building A5, International Enterprise Community, Tianjin, China
Email:info@kmdbioscience.com
Catalog Number | YR1422 |
---|---|
Product Name | Anti-Human CD19 & CD3E Recombinant Antibody(Duvortuxizumab) |
Molecular Name | Duvortuxizumab |
Alias | Anti-CD19 & CD3E Recombinant Antibody, Research Grade Duvortuxizumab |
CAS Number | 1831098-91-9 |
Target | CD19 & CD3E[Homo sapiens] |
Isotype | scFv -h-CH2-CH3(_scFv)_h-CH2-CH3 |
Clonity | Monoclonal |
Source | CHO Cells |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Buffer | PBS, pH7.5 |
Background | Duvortuxizumab (INN) is a chimeric/humanized monoclonal antibody designed for the treatment of B-cell malignancies. This drug was developed by Janssen Global Services. |
Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Note | This product is for research use only. |